Detalhe da pesquisa
1.
Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study.
Lancet Oncol
; 23(6): 781-792, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35576957
2.
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
N Engl J Med
; 379(24): 2342-2350, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30280658
3.
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
N Engl J Med
; 377(20): 1919-1929, 2017 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28885881
4.
Significance of lymph node involvement in local recurrence of colorectal cancer.
J Surg Oncol
; 120(4): 722-728, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31332806
5.
Phase I dose-escalation trial of afatinib, an irreversible ErbB family blocker, in combination with gemcitabine or docetaxel in patients with relapsed or refractory solid tumors.
Invest New Drugs
; 36(6): 1044-1059, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29808308
6.
First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease Control.
Oncology
; 90(2): 88-96, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26784946
7.
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies.
Eur J Cancer
; 200: 113587, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340384
8.
Prognostic Impact of TP53 Mutations in Metastatic Nonsquamous Non-small-cell Lung Cancer.
Clin Lung Cancer
; 2023 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38218680
9.
Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial.
Dig Liver Dis
; 55(4): 541-548, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36115817
10.
Survival after cytoreductive surgery for peritoneal metastases in colorectal cancer patients: Does a history of resected liver metastases worsen the prognosis?
Eur J Surg Oncol
; 48(4): 803-809, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34955316
11.
Safety and Efficacy of Dostarlimab in Patients With Recurrent/Advanced Non-small Cell Lung Cancer: Results from Cohort E of the Phase I GARNET Trial.
Clin Lung Cancer
; 23(7): e415-e427, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35729005
12.
PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon.
Cancer Discov
; 12(6): 1435-1448, 2022 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35398880
13.
Transient Vision Loss - A Rare Oxaliplatin-Induced Ophthalmologic Side Effect: A Report of Two Cases.
Case Rep Oncol
; 14(1): 483-486, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33976624
14.
A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes.
Target Oncol
; 16(6): 801-811, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34661827
15.
Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumors.
Cancer Immunol Immunother
; 59(10): 1521-30, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20563721
16.
A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers.
Eur J Cancer
; 140: 37-44, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33039812
17.
Intra-abdominal recurrence from colorectal carcinoma: Differences and similarities between local and peritoneal recurrence.
Surg Oncol
; 32: 23-29, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31707314
18.
Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer.
Cancers (Basel)
; 12(6)2020 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32527039
19.
Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non-small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study.
Eur J Cancer
; 131: 27-36, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32276179
20.
Randomized Phase II Trial Evaluating Treatment with EGFR-TKI Associated with Antiestrogen in Women with Nonsquamous Advanced-Stage NSCLC: IFCT-1003 LADIE Trial.
Clin Cancer Res
; 26(13): 3172-3181, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32144133